NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Liu, Minji ^a   Peng, Ya ^a   Wang, Xiaoyan ^a   Guo, Qin ^a   Shen, Shourong ^a   Li, Guiyuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MESSENGER RNA; TUMOR SUPPRESSOR PROTEIN; AZACITIDINE; DNA METHYLTRANSFERASE; DRUG DERIVATIVE; ENZYME INHIBITOR; MEMBRANE PROTEIN; NGX6 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CANCER CELL CULTURE; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA FLANKING REGION; DNA METHYLATION; DNA SEQUENCE; DOWN REGULATION; ENZYME ASSAY; EPIGENETICS; GENE EXPRESSION; GENE INACTIVATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; NASOPHARYNGEAL CARCINOMA ASSOCIATED GENE 6; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; AGE; AGED; CANCER STAGING; CELL STRAIN HT29; CHI SQUARE DISTRIBUTION; COLORECTAL TUMOR; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGE FACTORS; AGED; AZACITIDINE; CHI-SQUARE DISTRIBUTION; CLONING, MOLECULAR; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA MODIFICATION METHYLASES; DOWN-REGULATION; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HT29 CELLS; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 77951240364     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-160     Document Type: Article

References (23)

1. Jones PA, Baylin SB. the epigenomics of cancer. Cell 2007, 128(4):683-692. 17320506, 10.1016/j.cell.2007.01.029.
2. Jubb AM, Bell SM, Quirke P. Methylation and colorectal cancer. J Pathol 2001, 195:111-134. 11568897, 10.1002/path.923.
3. Yang JB, Bin LH, Li ZH, Zhang XH, Qian J, Zhang BC, Zhou M, Xie Y, Deng LW, Li GY. Refined localization and cloning of a novel putative tumor suppressor gene associated with nasopharyngeal carcinoma on chromosome 9p21-22. Clin J Cancer 2000, 19(1):6-9.
4. Fan SQ, Zhang WL, Peng SP, Zhou M, Li GY. Study of in situ expression of NGX6 gene in the several common types of cancer and its clinical significance. Progress in Biochemistry and Biophysics 2008, 35(9):1014-1020.
5. Zhang XM, Sheng SR, Wang XY, Wang JR, Li J. Expression of tumor relatedgenes NGX6 in gastric and colorectal cancer. World Chinese Journal of Digestology 2002, 10(8):873-876.
6. Wang XY, Shen SR, Liu HY, Zhang XM, Peng C, Huang H, Liu F, Li XL, Li GY. Effects of tumor suppressor gene NGX6 on growth of human colon cancer cell line HT-29. World Chin J Digestol 2004, 12(3):574-579.
7. Xiao ZM, Shen SR, Lian P, et al. Intraspleenic tumor modle of nude mice in the anti-metastasis roles of NGX6 gene against colon cancer. Journal of Central South University (Medical Sciences) 2007, 32(5):753-757.
8. Liu F, Shen SR, Li HT, Wang XY, Peng Y, Liao MT, Guo Q. Effects of NGX6 on the transcriptional activation of beta-catenin/TCF/LEF in Wnt/beta-catenin signal pathway. Journal of Central South University (Medical Sciences) 2007, 32(6):985-991.
9. Wang XY, Shen SR, Liu F, Peng Y, Li GY, Fan SQ. Inhibitory effects of NGX6 gene on EGFR/K-r as/JNK/c-Jun/cyclin D1 signal pathway in the colon cancer. Progress in Biochemistry and Biophysics 2008, 35(5):570-576.
10. Peng Y, Li HT, Wu MH, Wang XY, Fan SQ, Liu F, Xiang B, Guo Q, Tang XY, Shen SR. NGX6 inhibits AP-1 and Ets-1 expression and down-regulates cyclin D1 in human colorectal cancer. Acta Biochim Biophys Sin 2009, 41(6):504-514. 19499154, 10.1093/abbs/gmp039.
11. Genomatix GEMlauncher PromoterInspector. Search for the mammalian promoters Genomatix GEMlauncher., http://www.genomatix.de/cgi-bin/promoterinspector_prof/promoterinspector.pl
12. FirstEF: first-exon and promoter prediction program for human DNA. , http://rulai.cshl.org/tools/FirstEF/
13. European Bioinformatic Institute CpGPlot program. European Bioinformatic Institute., http://www.ebi.ac.uk/emboss/cpgplot
14. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987, 196(2):261-282. 3656447, 10.1016/0022-2836(87)90689-9.
15. University Bioinformatic Institute MethPrimer-Design Primers for Methylation PCRs. University Bioinformatic Institute., http://www.urogene.org/methprimer/
16. Jubb AM, Bell SM, Quirke P. Methylation and colorectal cancer. J Pathol 2001, 195:111-134. 11568897, 10.1002/path.923.
17. Wang XY, Shen SR, Liu HY, Li XL, Fan SQ. Effects of NGX6 Gene on Cell Cycle in Colon Cancer Cell Line HT-29. Progress in Biochemistry and Biophysics 2006, 33(1):45-50.
18. Lian P, Guo Q, Peng Y, Xiao ZM, Liu F, Wang XY, Shen SR, Li GY. The Role of NGX6 Gene on Apoptosis of Human Colon Cancer. Progress in Biochemistry and Biophysics 2008, 35(10):1154-1160.
19. Kim HC, Lee HJ, Roh SA, Kim JS, Yu CS, Kim JC. CpG island methylation in familial colorectal cancer patients not fulfilling the Amsterdam criteria. J Korean Med Sci 2008, 23(2):270-277. 18437011, 10.3346/jkms.2008.23.2.270, 2526421.
20. Vilkin A, Niv Y, Nagasaka T, Morgenstern S, Levi Z, Fireman Z, Fuerst F, Goel A, Boland CR. Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel. Cancer 2009, 115(4):760-769. 19127559, 10.1002/cncr.24019, 2855188.
21. Kumar K, Brim H, Giardiello F, Nouraie M, Lee EL, Ashktorab H. Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans. Clin Cancer Res 2009, 15(4):1155-1161. 19190129, 10.1158/1078-0432.CCR-08-1029, 2713502.
22. Yi JM, Tsai HC, Glöckner SC, Lin S, Ohm JE, Easwaran H, James CD, Costello JF, Riggins G, Eberhart CG, Laterra J, Vescovi AL, Ahuja N, Herman JG, Schuebel KE, Baylin SB. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res 2008, 68(19):8094-8103. 18829568, 10.1158/0008-5472.CAN-07-6208, 2744404.
23. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006, 31(2):89-97. 16403636, 10.1016/j.tibs.2005.12.008.